Projekt
SAKK 22/10: A randomized phase II trial of pertuzumab in combination with trastuzumab with or without chemothera-py, both followed by T-DM1 in case of progression, in pa-tients with HER2-positive metastatic breast cancer
Automatisch geschlossen · 2013 bis 2015
Weder Patrik, Ruhstaller Thomas, Hasler-Strub Ursula, Maier Reinhard, Öhlschlegel Christian, Riniker Salome, Kaelin Martin, Hochstrasser Andreas, Thürlimann Beat
Weder, Patrik
9
13
Ruhstaller, Thomas
83
24
Hasler-Strub, Ursula
5
11
Maier, Reinhard
Leitung Clinical Trials Unit (CTU) (operationell)wissenschaftliche(r) Mitarbeiter/in
Medizinisches Forschungszentrum, Clinical Trials Unit · Dept. Direktion
24
5
Öhlschlegel, Christian
40
4
Riniker, Salome
4
11
Kaelin, Martin
3
2
Hochstrasser, Andreas
3
1
Thürlimann, Beat
259
14